Modeling Reveals How Direct-Acting Antivirals Redirect HBV Capsid Assembly Pathways to Noninfectious Products
Layne B. Frechette, Smriti Pradhan, Farzaneh Mohajerani, Carolina Pérez-Segura, Jodi A. Hadden‐Perilla, Adam Zlotnick, Michael F. Hagan
The paper uses a kinetic Monte Carlo model to simulate how CAMs alter HBV capsid assembly, revealing mechanisms that lead to noninfectious structures.
bioRxiv · May 26, 2026 · PreprintBiophysics